Category: Patent Litigation
-
SEP holders now have four ways of avoiding UK interim licenses; Acer, ASUS defeat pokes hole in their (F)RAND defenses in Nokia ITC case
Chinese SEP holders may even have a fifth way of avoiding UK FRAND jurisdiction. Meanwhile, for Acer and ASUS, the recent UK appellate ruling complicates everything in their disputes with Nokia.
-
USPTO Director dismisses more inter partes reviews under new rules against petitioners taking different positions on validity in court
Director John Squires is continuing to intervene to stop what he and others see as “bad faith” use of IPRs.
-
Actelion falls foul of disclosure-dedication rule, prosecution estoppel in Federal Circuit challenge to Mylan’s hypertension generic
The Federal Circuit agreed that there was neither literal infringement, nor infringement under the doctrine of equivalents.
-
IP winners, litigation funding dangers and speaking the C-suite language: IP Dealmakers closing highlights
A debate on whether litigation funding is unjustifiably driving up the value of patents, advice for patent executives on how best to talk to the C-suite, and what makes a “winning” IP team were among the highlights of the third day of IP Dealmakers Europe.
-
Via licensor Philips settles Qi dispute with Belkin; Renault takes patent license from Broadcom
Based on decisions by the UPC to close cases, two significant SEP disputes have apparently been settled: Philips-Belkin (a win for Via in all likelihood) and Broadcom-Renault.
-
Brazilian patent judge: “other jurisdictions cannot stop us”; ready to talk to judges in other jurisdictions “to cooperate, not to submit”
Judge Victor Torres sent out important message to judges in other jursidictions during the course of an Oxfirst webinar on Brazilian injunctions.
-
Munich appeals court lifts injunction against Deutsche Telekom fixed-line offering, clarifies approach to heterogeneous instrumentalities
The patent holder accused specific Deutsche Telekom offerings of infringement and differentiated between the network infrastructure products powering them. But the injunction was not tailored to particular setups, which would have left certain questions to the enforcement proceedings.
-
CureVac expands Spikevax patent fight to UPC with new action against Moderna in Hague LD
In a significant patent battle for mRNA vaccines, CureVac has now joined others in suing in the UPC, taking the dispute with Moderna, which started in Delaware, to the Hague LD.
-
SEP value transparency, AI lawyers, political tension: initial highlights from IP Dealmakers
The need for greater transparency in the value of standards, a debate on the increasing use of AI in patent litigation claims, and geopolitical considerations in IP enforcement were among the highlights of the first and second days of the third annual IP Dealmakers in London this week.